Tharimmune director files Form 3, no holdings
Tharimmune, Inc. director Jill E. Sommers filed a Form 3 reflecting her status as a director and indicating that she beneficially owns no securities of Tharimmune.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tharimmune, Inc. director Jill E. Sommers filed a Form 3 reflecting her status as a director and indicating that she beneficially owns no securities of Tharimmune. The filing is dated for an event on January 30, 2026 and is filed by one reporting person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Tharimmune (THAR) disclose in this Form 3 filing?
Who is the reporting person in Tharimmune (THAR)’s latest Form 3?
What is the event date reported in Tharimmune (THAR)’s Form 3 for director Sommers?
AI-generated analysis. How Rhea-AI works. Not financial advice.